According to Karuna Therapeutics's latest financial reports the company has $1.43 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $1.12 B | 127.54% |
2021-12-31 | $0.49 B | 53.26% |
2020-12-31 | $0.32 B | -17.22% |
2019-12-31 | $0.38 B | 330.23% |
2018-12-31 | $90.5 M | 4560.61% |
2017-12-31 | $1.94 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | $0.26 B | -81.59% | ๐บ๐ธ USA |